Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system

被引:121
作者
Kawada, H
Ando, K
Tsuji, T
Shimakura, Y
Nakmura, Y
Chargui, J
Hagihara, M
Itagaki, H
Shimizu, T
Inokuchi, S
Kato, S
Hotta, T [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Internal Med, Div Hematol, Isehara, Kanagawa 2591193, Japan
[2] Tokai Univ, Sch Med, Res Ctr Genet Engn & Cell Transplantat, Isehara, Kanagawa 2591193, Japan
[3] Tokai Univ, Sch Med, Dept Pediat, Isehara, Kanagawa 2591193, Japan
[4] Tokai Univ Hosp, Cell Transfus Ctr, Kanagawa, Japan
[5] JT Inc, Pharmaceut Frontier Res Lab, Div Hematol, Kanagawa, Japan
基金
日本学术振兴会;
关键词
ex vivo expansion; progenitor cells; stromal cell line; thrombopoietin; Flk-2/Flt-3; ligand;
D O I
10.1016/S0301-472X(99)00012-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cell numbers limit the widespread clinical use of cord blood (CB) for gene therapy and marrow replacement in adults; a simple and effective method for ex vivo expansion of CB primitive progenitor cells (PPC) is required, Recently, the combination of thrombopoietin (TPO) and Flk-2/Flt-3 ligand (FL-2) was reported to support slow proliferation of CB-PPC in stroma-free liquid culture. We established a novel culture system in which the murine stromal cell line HESS-5 dramatically supports the rapid expansion of cryopreserved CB-PPC in synergy with TPO/FL-2, Furthermore, while HESS-5 cells directly adhered to human progenitors during culture, the cultured human cells could easily be harvested without contamination by HESS-5 cells. Within 7 days of culture, a 100-fold increase in CD34(bright)/CD38(dim) cells was obtained in serum-containing culture, When HESS-5 cells were physically separated from human progenitor cells in the presence of TPO/FL-2, synergy was blocked, suggesting that HESS-5 cells support proliferation of PPC by direct cell-to-cell interaction, The hematopoietic-supportive effects of this xenogeneic coculture system were then assessed in a very short-term (5 days) serum-free culture, Expansion was further enhanced by addition of stem cell factor (SCF) or interleukin-3 (IL-3), As a result, a 50- to 100-fold increase in CD34(bright)/CD38(dim) cells was noted, Colony-forming units in culture (CFU-C) and mixed colonies (CFU-GER IRI) were enhanced by 10- to 30-fold and 10- to 20-fold, respectively, Moreover, generation of long-term-culture-initiating cells (LTC-IC) from CD34(bright)/CD38(dim) cells was amplified by 25-fold, The severe-combined immunodeficient (SCID) mouse-repopulating cell (SRC) assay confirmed extensive ability of the expanded cells to reconstitute long-term hematopoiesis. These results indicate that this xenogeneic coculture system, in combination with human cytokines, can rapidly generate PPC from cryopreserved CB, (C) 1999 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:904 / 915
页数:12
相关论文
共 31 条
[21]   Flt3 ligand induces proliferation of quiescent human bone marrow CD34(+)CD38(-) cells and maintains progenitor cells in vitro [J].
Shah, AJ ;
Smogorzewska, EM ;
Hannum, C ;
Crooks, GM .
BLOOD, 1996, 87 (09) :3563-3570
[22]   FUNCTIONAL-CHARACTERIZATION OF INDIVIDUAL HUMAN HEMATOPOIETIC STEM-CELLS CULTURED AT LIMITING DILUTION ON SUPPORTIVE MARROW STROMAL LAYERS [J].
SUTHERLAND, HJ ;
LANSDORP, PM ;
HENKELMAN, DH ;
EAVES, AC ;
EAVES, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) :3584-3588
[23]   EVALUATION OF EX-VIVO EXPANSION POTENTIAL OF CORD-BLOOD AND BONE-MARROW HEMATOPOIETIC PROGENITOR CELLS USING CELL TRACKING AND LIMITING DILUTION ANALYSIS [J].
TRAYCOFF, CM ;
KOSAK, ST ;
GRIGSBY, S ;
SROUR, EF .
BLOOD, 1995, 85 (08) :2059-2068
[24]  
TRAYCOFF CM, 1994, EXP HEMATOL, V22, P215
[25]  
Tsuji T, 1996, LEUKEMIA, V10, P803
[26]  
Tsuji T., 1997, Blood, V90, p366A
[27]   MACROPHAGE INFLAMMATORY PROTEIN 1-ALPHA, INTERLEUKIN-3 AND DIFFUSIBLE MARROW STROMAL FACTORS MAINTAIN HUMAN HEMATOPOIETIC STEM-CELLS FOR AT LEAST 8 WEEKS IN-VITRO [J].
VERFAILLIE, CM ;
CATANZARRO, PM ;
LI, WN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :643-649
[28]  
VERFAILLIE CM, 1993, BLOOD, V82, P2045
[29]  
VORMOOR J, 1994, BLOOD, V83, P2489
[30]  
WILLIAMS DA, 1993, BLOOD, V81, P3169